The selective sphingosine 1-phosphate receptor 1 agonist ponesimod protects against lymphocyte-mediated tissue inflammation von Piali, Luca, Froidevaux, Sylvie, Hess, Patrick, Nayler, Oliver, Bolli, Martin H, Schlosser, Eva, Kohl, Christopher, Steiner, Beat, Clozel, Martine

Volltext

Cenerimod, a selective S1P1 receptor modulator, improves organ-specific disease outcomes in animal models of Sjögren’s syndrome von Gerossier, Estelle, Nayar, Saba, Froidevaux, Sylvie, Smith, Charlotte G., Runser, Celine, Iannizzotto, Valentina, Vezzali, Enrico, Pierlot, Gabin, Mentzel, Ulrich, Murphy, Mark J., Martinic, Marianne M., Barone, Francesca

Volltext

A chromosomal region on ECA13 is associated with maxillary prognathism in horses von Signer-Hasler, Heidi, Neuditschko, Markus, Koch, Christoph, Froidevaux, Sylvie, Flury, Christine, Burger, Dominik, Leeb, Tosso, Rieder, Stefan

Volltext

Somatostatin analogs and radiopeptides in cancer therapy von Froidevaux, Sylvie, Eberle, Alex N.

Volltext

Preclinical to clinical translation of cenerimod, a novel S1P1 receptor modulator, in systemic lupus erythematosus von Strasser, Daniel S, Froidevaux, Sylvie, Sippel, Virginie, Gerossier, Estelle, Grieder, Ursula, Pierlot, Gabin M, Kieninger-Graefitsch, Andrea, Vezzali, Enrico, Stalder, Anna K, Renault, Bérengère, Ryge, Jesper, Hart, Aaron, Mentzel, Ulrich, Groenen, Peter M A, Keller, Marcel P, Trendelenburg, Marten, Martinic, Marianne M, Murphy, Mark J

Volltext

Neuroendocrine tumor targeting: Study of novel gallium‐labeled somatostatin radiopeptides in a rat pancreatic tumor model von Froidevaux, Sylvie, Eberle, Alex N., Christe, Martine, Sumanovski, Lazar, Heppeler, Axel, Schmitt, Jörg S., Eisenwiener, Klaus, Beglinger, Christoph, Mäcke, Helmut R.

Volltext

Discovery and Characterization of a New Class of C5aR1 Antagonists Showing In Vivo Activity von Hubler, Francis, Renneberg, Dorte, Siendt, Hervé, Stamm, Simon, Hilpert, Kurt, Caroff, Eva, Delahaye, Stephane, Froidevaux, Sylvie, Murphy, Mark J.

Volltext

Design, Synthesis, and Pharmacological Evaluation of Benzimidazolo-thiazoles as Potent CXCR3 Antagonists with Therapeutic Potential in Autoimmune Diseases: Discovery of ACT-672125 von Caroff, Eva, Meyer, Emmanuel A., Äänismaa, Päivi, Froidevaux, Sylvie, Keller, Marcel, Piali, Luca

Volltext

Discovery and In Vivo Evaluation of ACT-660602: A Potent and Selective Antagonist of the Chemokine Receptor CXCR3 for Autoimmune Diseases von Meyer, Emmanuel A., Äänismaa, Päivi, Froidevaux, Sylvie, Keller, Marcel, Piali, Luca, Caroff, Eva

Volltext

Discovery of the Novel, Orally Active, and Selective LPA1 Receptor Antagonist ACT-1016-0707 as a Preclinical Candidate for the Treatment of Fibrotic Diseases von Lescop, Cyrille, Birker, Magdalena, Brotschi, Christine, Bürki, Cédric, Morrison, Keith, Froidevaux, Sylvie, Delahaye, Stéphane, Nayler, Oliver, Bolli, Martin H.

Volltext

Discovery of a Novel Orally Active, Selective LPA Receptor Type 1 Antagonist, 4‑(4-(2-Isopropylphenyl)-4-((2-methoxy-4-methylphenyl)carbamoyl)piperidin-1-yl)-4-oxobutanoic Acid, wi... von Lescop, Cyrille, Brotschi, Christine, Williams, Jodi T., Sager, Christoph P., Birker, Magdalena, Morrison, Keith, Froidevaux, Sylvie, Delahaye, Stéphane, Nayler, Oliver, Bolli, Martin H.

Volltext

Cenerimod, a selective S1P(1) receptor modulator, improves organ-specific disease outcomes in animal models of Sjogren's syndrome von Gerossier, Estelle, Nayar, Saba, Froidevaux, Sylvie, Smith, Charlotte G., Runser, Celine, Iannizzotto, Valentina, Vezzali, Enrico, Pierlot, Gabin, Mentzel, Ulrich, Murphy, Mark J., Martinic, Marianne M., Barone, Francesca

Volltext

Discovery of Clinical Candidate ACT-777991, a Potent CXCR3 Antagonist for Antigen-Driven and Inflammatory Pathologies von Meyer, Emmanuel A., Äänismaa, Päivi, Ertel, Eric A., Hühn, Eva, Strasser, Daniel S., Rey, Markus, Murphy, Mark J., Martinic, Marianne M., Pouzol, Laetitia, Froidevaux, Sylvie, Keller, Marcel P., Caroff, Eva

Volltext

Preclinical Comparison in AR4–2J Tumor-Bearing Mice of Four Radiolabeled 1,4,7,10-Tetraazacyclododecane-1,4,7,10-Tetraacetic Acid-Somatostatin Analogs for Tumor Diagnosis and Inter... von Froidevaux, Sylvie, Heppeler, Axel, Eberle, Alex N., Meier, Anne-Marie, Häusler, Marianne, Beglinger, Christoph, Béhé, Martin, Powell, Pia, Mäcke, Helmut R.

Volltext

Preclinical to clinical translation of cenerimod, a novel S1P(1) receptor modulator, in systemic lupus erythematosus von Strasser, Daniel S., Froidevaux, Sylvie, Sippel, Virginie, Gerossier, Estelle, Grieder, Ursula, Pierlot, Gabin M., Kieninger-Graefitsch, Andrea, Vezzali, Enrico, Stalder, Anna K., Renault, Berengere, Ryge, Jesper, Hart, Aaron, Mentzel, Ulrich, Groenen, Peter M. A., Keller, Marcel P., Trendelenburg, Marten, Martinic, Marianne M., Murphy, Mark J.

Volltext

A gallium-labeled DOTA-alpha-melanocyte- stimulating hormone analog for PET imaging of melanoma metastases von Froidevaux, Sylvie, Calame-Christe, Martine, Schuhmacher, Jochen, Tanner, Heidi, Saffrich, Rainer, Henze, Markus, Eberle, Alex N

Volltext

Melanoma targeting with DOTA-alpha-melanocyte-stimulating hormone analogs: structural parameters affecting tumor uptake and kidney uptake von Froidevaux, Sylvie, Calame-Christe, Martine, Tanner, Heidi, Eberle, Alex N

Volltext

Additional file 1 of Cenerimod, a selective S1P1 receptor modulator, improves organ-specific disease outcomes in animal models of Sjögren’s syndrome von Gerossier, Estelle, Nayar, Saba, Froidevaux, Sylvie, Smith, Charlotte G., Runser, Celine, Iannizzotto, Valentina, Vezzali, Enrico, Pierlot, Gabin, Mentzel, Ulrich, Murphy, Mark J., Martinic, Marianne M., Barone, Francesca

Volltext bestellen

Cenerimod, a novel selective S1P1 receptor modulator with unique signaling properties von Piali, Luca, Birker‐Robaczewska, Magdalena, Lescop, Cyrille, Froidevaux, Sylvie, Schmitz, Nicole, Morrison, Keith, Kohl, Christopher, Rey, Markus, Studer, Rolf, Vezzali, Enrico, Hess, Patrick, Clozel, Martine, Steiner, Beat, Bolli, Martin H., Nayler, Oliver

Volltext

O38 Preclinical and clinical characterization of cenerimod, a potent, selective, and orally active sphingosine-1-phosphate receptor 1 modulator in SLE von Strasser, Daniel S, Gerossier, Estelle, Sippel, Virginie, Grieder, Ursula, Kieninger-Graefitsch, Andrea, Pierlot, Gabin, Farine, Hervé, Kulig, Paulina, Keller, Marcel, Froidevaux, Sylvie, Trendelenburg, Marten, Murphy, Mark, Martinic, Marianne

Volltext